Clinical Evidence

The Cutimed® range is proven to help in advanced wound management. On this page, you can view and explore a selection of clinical studies that underline the performance of the Cutimed® portfolio.

Clean & Debride

Cutimed® DebriClean
Evans-Charles S. Cutimed DebriClean: a 23-patient wound bed preparation product evaluation. Wounds UK. 2021; Vol 17, No 13. Read more

Manage Infection

Sorbact® Technology

Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18. Read more

Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570. Read more

Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127. Read more

Stephen-Haynes J et al. Cutimed Siltec foam and Cutimed Sorbact gel dressings: a clinical audit. Wounds UK. 2010;6:130-136. Read more

Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392. Read more

Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529. Read more

Haycocks S et al. Use of a DACC-coated antimicrobial dressing in people with diabetes and a history of foot ulceration. Wounds UK. 2011;7:108-114. Read more

Chadwick P et al. Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review. J Wound Care. 2019;28(6):370-382. Read more

Dwiyana et al. Clinical efficacy of dialkylcarbamoylchloride-coated cotton acetate dressing versus combination of normal saline dressing and 2% mupirocin ointment in infected wounds of epidermolysis bullosa. Dermatol Ther. 2019;32(5):e13047. Read more

Rippon et al. Antimicrobial stewardship strategies in wound care: evidence to support the use of dialkylcarbamoyl chloride (DACC)- coated wound dressings. J Wound Care. 2021;30(4):284-296. Read more

Ciprandi et al. Meeting the Challenges in Pediatric Wound Care: Our 15-Year Experience with Dialkylcarbamoyl Chloride-Coated Dressing Technology in Acute and Chronic Wounds. Chronic Wound Care Management and Research. 2022;9:23-33. Read more

Lee JW et al. A comparison between DACC with chlorhexidine acetate-soaked paraffin gauze and foam dressing for skin graft donor sites. J Wound Care. 2018;27(1):28-35. Read more

Ciliberti M et al. The Effect of a Bacteria- and Fungi- binding Mesh Dressing on the Bacterial Load of Pressure Ulcers Treated With Negative Pressure Wound Therapy: A Pilot Study. Wounds. 2016;28(11):408-420. Read more

Grothier L & Stephenson J. An audit to determine the clinical effectiveness of a pathway for managing wound infection. Wounds UK. 2015;11:30-7. Read more

Ljungh A et al. Using the principle of hydrophobic interaction to bind and remove wound bacteria. J Wound Care. 2006;15(4):175-180.​ Read more

Susilo YB et al. Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wound dressing. J Wound Care. 2022;31(6):502-509. Read more

Bateman et al. Evidence is building to support using a DACC-coated antimicrobial wound contact layer with NPWT. Wounds UK. 2015; 11:1. Read more

Haycocks S & Chadwick P. Use of DACC-coated dressings in diabetic foot ulcers: A case series. Diabet Foot J. 2011;14:133-37. Read more

Powell Get al. Managing venous leg ulcers using compression therapy and dressings. Br J Nurs. 2015;24(15):S42-S49. Read more

Manage Infection & Exudate

Sorbact® Technology
See the evidence listed under Manage Infection - Sorbact® Technology.
Cutimed® Sorbion® Sorbact®
See the evidence listed under Manage Infection - Sorbact® Technology.
Cutimed® Siltec® Sorbact®

See the evidence listed under Manage Infection - Sorbact® Technology.

Seckam AM et al. Clinical performance and quality of life impact of an absorbent bacteria-binding foam dressing. British Journal of nursing. 2021;30. Read more

Manage Exudate

Cutimed® Siltec®

Bateman SD. 150 patient experiences with a soft silicone foam dressing. Br J Nurs. Jun 25-Jul 8, 2015;24(12):S16, S18-23. Read more

King B. A clinical evaluation of 20 patients when using a new absorbent silicone foam wound dressing: Cutimed Siltec B. Wounds UK. 2018;Vol 14. No 3. Read more

Seckam A. A multicentre, observational evaluation of the product characteristics of two absorbent foam dressings. Br J Nurs. 2019 Jun 27;28(12):S10-S17. Read more

Bateman SD. The challenge of skin tears and lacerations in an emergency environment. Wounds UK. 2014; 10. 94-99. Read more

Cutimed® Sorbion®

Sutherland L. A modern dressing range to meet today's wound care challenges. JCN. 2013;27(5):35-40. Read more

Romanelli M et al. A pilot study evaluating the wound and skin care performances of the Hydration Response Technology dressing - a new concept of debridement, J Wound Technology. 2009; Vol. 5.

Panca M et al. Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs. J Wound Care. 2013 Mar;22(3):109-10, 112-8. Read more

Romanelli M et al. Exudate management made easy. Wounds Int. 2010; 1(2):1-6. Read more

Todd M et al. Managing ulceration and lymphorrhea in chronic oedema. Br J Community Nurs. 2017;22 Suppl 5(Sup5):S34-S41. Read more

Cutting KF. Managing wound exudate using a super-absorbent polymer dressing: a 53-patient clinical evaluation. Journal of Wound Care. 2009;18(5):200-05. Read more

Complementary

Cuticell® Contact
Derbyshire A. Using a silicone-based dressing as a primary wound contact layer. British Journal of Nursing. 2014;23 Suppl 20: S14-S20. Read more